364 related articles for article (PubMed ID: 21224849)
1. TGF-β regulates isoform switching of FGF receptors and epithelial-mesenchymal transition.
Shirakihara T; Horiguchi K; Miyazawa K; Ehata S; Shibata T; Morita I; Miyazono K; Saitoh M
EMBO J; 2011 Feb; 30(4):783-95. PubMed ID: 21224849
[TBL] [Abstract][Full Text] [Related]
2. TGF-β drives epithelial-mesenchymal transition through δEF1-mediated downregulation of ESRP.
Horiguchi K; Sakamoto K; Koinuma D; Semba K; Inoue A; Inoue S; Fujii H; Yamaguchi A; Miyazawa K; Miyazono K; Saitoh M
Oncogene; 2012 Jun; 31(26):3190-201. PubMed ID: 22037216
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of Lnc-Spry1 mediates TGF-β-induced epithelial-mesenchymal transition by transcriptional and posttranscriptional regulatory mechanisms.
Rodríguez-Mateo C; Torres B; Gutiérrez G; Pintor-Toro JA
Cell Death Differ; 2017 May; 24(5):785-797. PubMed ID: 28186499
[TBL] [Abstract][Full Text] [Related]
4. EED regulates epithelial-mesenchymal transition of cancer cells induced by TGF-β.
Oktyabri D; Tange S; Terashima M; Ishimura A; Suzuki T
Biochem Biophys Res Commun; 2014 Oct; 453(1):124-30. PubMed ID: 25264103
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of epithelial and mesenchymal markers by deltaEF1 proteins in epithelial mesenchymal transition induced by TGF-beta.
Shirakihara T; Saitoh M; Miyazono K
Mol Biol Cell; 2007 Sep; 18(9):3533-44. PubMed ID: 17615296
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of FXYD3 is induced by transforming growth factor-β signaling via ZEB1/δEF1 in human mammary epithelial cells.
Yamamoto H; Mukaisho K; Sugihara H; Hattori T; Asano S
Biol Pharm Bull; 2011; 34(3):324-9. PubMed ID: 21372379
[TBL] [Abstract][Full Text] [Related]
7. Identification of integrin α3 as a molecular marker of cells undergoing epithelial-mesenchymal transition and of cancer cells with aggressive phenotypes.
Shirakihara T; Kawasaki T; Fukagawa A; Semba K; Sakai R; Miyazono K; Miyazawa K; Saitoh M
Cancer Sci; 2013 Sep; 104(9):1189-97. PubMed ID: 23786209
[TBL] [Abstract][Full Text] [Related]
8. DA-Raf-Mediated Suppression of the Ras--ERK Pathway Is Essential for TGF-β1-Induced Epithelial-Mesenchymal Transition in Alveolar Epithelial Type 2 Cells.
Watanabe-Takano H; Takano K; Hatano M; Tokuhisa T; Endo T
PLoS One; 2015; 10(5):e0127888. PubMed ID: 25996975
[TBL] [Abstract][Full Text] [Related]
9. Notch3 is important for TGF-β-induced epithelial-mesenchymal transition in non-small cell lung cancer bone metastasis by regulating ZEB-1.
Liu L; Chen X; Wang Y; Qu Z; Lu Q; Zhao J; Yan X; Zhang H; Zhou Y
Cancer Gene Ther; 2014 Sep; 21(9):364-72. PubMed ID: 25080992
[TBL] [Abstract][Full Text] [Related]
10. Wnt signaling induces epithelial-mesenchymal transition with proliferation in ARPE-19 cells upon loss of contact inhibition.
Chen HC; Zhu YT; Chen SY; Tseng SC
Lab Invest; 2012 May; 92(5):676-87. PubMed ID: 22391957
[TBL] [Abstract][Full Text] [Related]
11. Keratin 13 gene is epigenetically suppressed during transforming growth factor-β1-induced epithelial-mesenchymal transition in a human keratinocyte cell line.
Hatta M; Miyake Y; Uchida K; Yamazaki J
Biochem Biophys Res Commun; 2018 Feb; 496(2):381-386. PubMed ID: 29326042
[TBL] [Abstract][Full Text] [Related]
12. Addiction of mesenchymal phenotypes on the FGF/FGFR axis in oral squamous cell carcinoma cells.
Osada AH; Endo K; Kimura Y; Sakamoto K; Nakamura R; Sakamoto K; Ueki K; Yoshizawa K; Miyazawa K; Saitoh M
PLoS One; 2019; 14(11):e0217451. PubMed ID: 31682640
[TBL] [Abstract][Full Text] [Related]
13. Genetic and pharmacologic inhibition of mTORC1 promotes EMT by a TGF-β-independent mechanism.
Mikaelian I; Malek M; Gadet R; Viallet J; Garcia A; Girard-Gagnepain A; Hesling C; Gillet G; Gonzalo P; Rimokh R; Billaud M
Cancer Res; 2013 Nov; 73(22):6621-31. PubMed ID: 24078802
[TBL] [Abstract][Full Text] [Related]
14. Functional cooperation between Snail1 and twist in the regulation of ZEB1 expression during epithelial to mesenchymal transition.
Dave N; Guaita-Esteruelas S; Gutarra S; Frias À; Beltran M; Peiró S; de Herreros AG
J Biol Chem; 2011 Apr; 286(14):12024-32. PubMed ID: 21317430
[TBL] [Abstract][Full Text] [Related]
15. Transcription factor PREP1 induces EMT and metastasis by controlling the TGF-β-SMAD3 pathway in non-small cell lung adenocarcinoma.
Risolino M; Mandia N; Iavarone F; Dardaei L; Longobardi E; Fernandez S; Talotta F; Bianchi F; Pisati F; Spaggiari L; Harter PN; Mittelbronn M; Schulte D; Incoronato M; Di Fiore PP; Blasi F; Verde P
Proc Natl Acad Sci U S A; 2014 Sep; 111(36):E3775-84. PubMed ID: 25157139
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Plasminogen Activator Inhibitor-1 Attenuates Transforming Growth Factor-β-Dependent Epithelial Mesenchymal Transition and Differentiation of Fibroblasts to Myofibroblasts.
Omori K; Hattori N; Senoo T; Takayama Y; Masuda T; Nakashima T; Iwamoto H; Fujitaka K; Hamada H; Kohno N
PLoS One; 2016; 11(2):e0148969. PubMed ID: 26859294
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor signals regulate transforming growth factor-β-induced endothelial-to-myofibroblast transition of tumor endothelial cells via Elk1.
Akatsu Y; Takahashi N; Yoshimatsu Y; Kimuro S; Muramatsu T; Katsura A; Maishi N; Suzuki HI; Inazawa J; Hida K; Miyazono K; Watabe T
Mol Oncol; 2019 Aug; 13(8):1706-1724. PubMed ID: 31094056
[TBL] [Abstract][Full Text] [Related]
18. Activation of histamine H4 receptors decreases epithelial-to-mesenchymal transition progress by inhibiting transforming growth factor-β1 signalling pathway in non-small cell lung cancer.
Cai WK; Hu J; Li T; Meng JR; Ma X; Yin SJ; Zhao CH; He GH; Xu GL
Eur J Cancer; 2014 Apr; 50(6):1195-206. PubMed ID: 24447834
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor-2-mediated FGFR/Erk signaling supports maintenance of cancer stem-like cells in esophageal squamous cell carcinoma.
Maehara O; Suda G; Natsuizaka M; Ohnishi S; Komatsu Y; Sato F; Nakai M; Sho T; Morikawa K; Ogawa K; Shimazaki T; Kimura M; Asano A; Fujimoto Y; Ohashi S; Kagawa S; Kinugasa H; Naganuma S; Whelan KA; Nakagawa H; Nakagawa K; Takeda H; Sakamoto N
Carcinogenesis; 2017 Oct; 38(11):1073-1083. PubMed ID: 28927233
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor receptor and mutant p53 expand an esophageal cellular subpopulation capable of epithelial-to-mesenchymal transition through ZEB transcription factors.
Ohashi S; Natsuizaka M; Wong GS; Michaylira CZ; Grugan KD; Stairs DB; Kalabis J; Vega ME; Kalman RA; Nakagawa M; Klein-Szanto AJ; Herlyn M; Diehl JA; Rustgi AK; Nakagawa H
Cancer Res; 2010 May; 70(10):4174-84. PubMed ID: 20424117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
